Medbiome’s founder recently released a new version of the metaproteomic software called MetaLab 2.0, opening the door to accurate Post-Translational Modifications profiling at the microbiome level. https://pubs.acs.org/doi/10.1021/jasms.0c00083

MedBiome is pleased to announce that it will attend the digital China Bio Partnering Forum on Aug 25-27 2020. Looking forward to new partnerships with Chinese companies.